[Caution when paying by credit card]

In order to deal with recent security issues, Saisei Pharma has introduced 3D Secure 2.0 into its payment system.
Along with that, there is a possibility that problems may occur in some environments on the card payment screen at the time of purchase.
Please reload the screen of your device so that you can use our site in the latest state.

Latest Product Launch Campaign

Dear valued customers,
We are excited to announce our latest improved product with triple the active ingredients!
The product was used in Ukraine Clinical Trial and has proven excellent results for hospitalized covid-19 patients.

MAF Capsules Triple/bottle: 20,000JPY
MAF Capsules/bottle: 13,000JPY

Don’t miss this special offer and we wish you happy shopping with us and good health.

Thank you for your interest in our site. Please contact your local distributor.
We have an exclusive distributor for our products in Kazakhstan, Uzbekistan, Kyrgyzstan and Russia.


Information for US and Australian/NZ customers

Saisei Hawaii USA and Saisei Australia have started accepting orders from individuals and distributors. Note: some products are only available from our Japan store.

- Announcement: MAF Spray Production and Sales Discontinued -

Dear Valued Customers,

Thank you for your continued support.

With effect from 30 Sep 2021, we regret to inform you that the MAF Spray
production and sales have been discontinued.
It has been difficult to maintain the quality of the MAF Spray during shipping with
global rising temperatures as the product does not contain any artificial additives
or preservatives and a cold shipping option isn't available.

We recommend MAF Powder with the same efficacy as its replacement as
the MAF Powder is more stable and doesn’t need refrigeration which
makes it very convenient and safe for use.

We appreciate your kind understanding. If you have any questions,
please do not hesitate to contact us.

Saisei Pharma is conducting clinical trials of oral MAF in COVID-19 patients. Details are featured in Press Releases on some websites. Please check the links below:

[finanzen.ch] [advfn.com] [benzinga.com]

-Counterfeit products warning-

3rd Generation GcMAF was developed by Saisei Pharma for which we hold patents. There are fake GcMAF products sold online in Australia by a company which is registered in Hong Kong. Please be aware that 3rd Generation GcMAF products are only produced by Saisei Pharma. Any other products from other companies are fake products.

Unverified seller alert

We were informed that a company calling themselves "Japan Health" with the websites bio-japan.net and japan-health.net is claiming to be selling our products. This seller is unverified and we have never sold our products to them. Especially our Second Generation GcMAF vials are only sold from Saisei Mirai Clinics in Japan and we do not authorize anyone to re-sell them unless they are registered as a Medical Doctor with us and prescribing them to patients. We recommend ordering GcMAF only from a trusted and reliable source. If you are unsure of the source, please contact us to confirm.

<Shipping information>

Belarus/Ukraine/Russia: All deliveries have been suspended until further notice.
EU: EMS has been suspended until further notice. Only FedEx Priority is available currently.

Due to Covid-19 outbreaks, EMS has announced that they have suspended services to some countries. FedEx priority is available for those countries. Your order will be added charge for FedEx priority.

We are pleased to announce that EMS has resumed its service to the United States of America.

China- We cannot accept orders: Personally imported packages shipped to mainland China are being refused customs clearance due to strict regulations being implemented. (excluding Hong Kong and Macau).